 14. Female subject of childbearing potential who is unwilling to use acceptable methods of effective contraception during study treatment and through 3 months after the last dose of talimogene laherparepvec. Women of not childbearing potential: post-menopausal age 55 years with cessation of menses 12 months or 55 years but not spontaneous menses for at least 2 years or 55 years and spontaneous menses within the past 1 year, but currently amenorrheic eg, spontaneous or secondary to hysterectomy, and with postmenopausal gonadotropin levels luteinizing hormone and follicle-stimulating hormone levels 40 IUL or postmenopausal estradiol levels 5 ngdL or according to the definition of postmenopausal range for the laboratory involved or who have had a hysterectomy, bilateral salpingectomy, or bilateral oophorectomy. 